MenAfriVac: A 40 cent shot to clean up meningitis in Africa

The new MenAfriVac vaccine has dramatically reduced meningitis A rates in Africa. Data presented at the World Vaccines Congress (11-12 April 2012) by the Meningitis Vaccine Project revealed both a dramatic reduction in the overall number of meningitis cases, and an even more dramatic reduction in the incidence of disease caused by meningococcal A strain.

More from Anti-infective

More from Therapeutic Category